Year in Review: On Demand — Significance and Relevance of Recent Data Sets and Publications in the Management of Breast Cancer


Year in Review: On Demand — Significance and Relevance of Recent Data Sets and Publications
in the Management of Breast Cancer
Featuring key slides from the most important recent breast cancer presentations and publications and a video interview with Dr Hope S Rugo.
3 AMA PRA Category 1 Credits
To complete the Post-test and Educational Assessment and Credit Form, click here. A statement of CME credit will be issued for scores of 80% or better. Your statement of credit will be mailed to you within 3 weeks or may be printed online.

CDK4/6 Inhibitors in the Treatment of ER-Positive, HER2-Negative Breast Cancer (BC)

mTOR Inhibitors and Antiandrogens for ER-Positive BC

Adjuvant Therapy for BC

PARP Inhibitors for Advanced Disease

Role of Immune Checkpoint Inhibitors